Pharmaceutical Technology, Volume 39 Issue 17

August 6, 2015

A. Shanley

Outsourcing opportunity?

PharmTech: What role do contract research organizations (CROs) and contract manufacturing organizations (CMOs) play in drug repurposing? Are there any new business models that you are seeing in CMOs that work in this area?

Mucke: Right now, I think the potential of CROs in drug repurposing is not sufficiently well utilized, which is a shame.

PharmTech: So, how would a contract services partner fit in?

Mucke: With drug repurposing, you have a different starting point than you do for new drug entities, one that calls for a stronger partnership between sponsor and CRO.
Of course, you can just ask for specific studies from different contract companies and choose the least expensive one. A better strategy is to find a CRO or CMO with a clear understanding of what you want to do and make that company your partner. 

Read the full article here

Sign up for our eNewsletter today!


First Name

Cures Within Reach

All funds donated to Cures Within Reach may be tax deductible for federal income tax purposes.  CWR is recognized by the IRS as a 501(c)3 tax-exempt not-for-profit organization, tax ID 20-3620169.


Sunday the 24th. Copyright 2018 Cures Within Reach.